These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 14073083)
1. [REMOTE RESULTS OF THE TREATMENT OF PERIPHERAL VASCULAR DISEASES WITH BUTYL-NOR-SYMPATHOL (VASCULAT)]. KOWALSKA M Pol Tyg Lek; 1963 Jul; 18():1029-31. PubMed ID: 14073083 [No Abstract] [Full Text] [Related]
2. Experiences with thermography in peripheral vascular disease. Heerma van Voss SF Acta Chir Belg; 1968 May; 67(5):457-64. PubMed ID: 5742393 [No Abstract] [Full Text] [Related]
3. Experiences with thermography in peripheral vascular disease. van Voss H Acta Chir Belg; 1968 May; 67(5):457-64. PubMed ID: 5711962 [No Abstract] [Full Text] [Related]
4. [Our experience in antalgic therapy of peripheral arteriopathies]. Tufano R; Portolano F; Bimonte D Rass Int Clin Ter; 1971 Mar; 51(6):370-4. PubMed ID: 5553226 [No Abstract] [Full Text] [Related]
5. ADVANCES IN THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE. MARTIN P Practitioner; 1963 Oct; 191():453-9. PubMed ID: 14069131 [No Abstract] [Full Text] [Related]
6. Pathophysiology related to peripheral vascular disease. Wagner MM Nurs Clin North Am; 1986 Jun; 21(2):195-206. PubMed ID: 3517813 [TBL] [Abstract][Full Text] [Related]
7. [On cutaneous sensitivity to tobacco smoke in chronic peripheral arteriopathies]. Brassai Z; Horváth E; Spak L; Papp J; Csögör I; Ferencz L Med Interna (Bucur); 1973 Nov; 25(11):1385-92. PubMed ID: 4793901 [No Abstract] [Full Text] [Related]
8. Vascular disorders in leg arteries, approached by means of thermography. Buwalda G Bibl Radiol; 1969; 5():121-6. PubMed ID: 5762015 [No Abstract] [Full Text] [Related]
9. Beneficial effects of vitamin A niacin and riboflavin in the management of certain types of vascular conditions. FISKE S; FOX LP; CAVUSOGLU M Med Times; 1962 Oct; 90():1055-64. PubMed ID: 13945325 [No Abstract] [Full Text] [Related]
10. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495). Royer RJ Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343 [No Abstract] [Full Text] [Related]
11. VASCULAR DISEASES OF THE LIMBS. CARTIER GE Can Nurse; 1964 Mar; 60():224-32. PubMed ID: 14126081 [No Abstract] [Full Text] [Related]
13. CYCLANDELATE (CYCLOSPASMOL) IN THE TREATMENT OF PERIPHERAL CIRCULATORY DISEASES. SMITH AL Angiology; 1965 Jan; 16():1-7. PubMed ID: 14258038 [No Abstract] [Full Text] [Related]
14. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs]. Krakovskij NI; Taranovic VA Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665 [No Abstract] [Full Text] [Related]
15. [CONSIDERATIONS ON THE ACTIVITY OF A VASODILATOR: 1-(P-HYDROXYPHENYL)-2-(1-METHYL-2-PHENOXYETHYLAMINE)-PROPANOL-1-HYDROCHLORIDE (DUVADILAN)]. ANFOSSI F; GUARRAGGI A Minerva Cardioangiol; 1964 Mar; 12():123-7. PubMed ID: 14142071 [No Abstract] [Full Text] [Related]
16. [New data on the use of halidor in obliterative diseases of arteries of the extremities]. Zolotarevskiĭ VIa; Taranovich VA; Maksimova TV Klin Med (Mosk); 1969 Feb; 47(2):67-71. PubMed ID: 5379263 [No Abstract] [Full Text] [Related]
18. [Therapeutic-preventive aid in obliterative arterial diseases of the extremities in ambulatory practice]. Ivanov AIa; Nazarov GD Vestn Khir Im I I Grek; 1967 Sep; 99(9):123-8. PubMed ID: 5617485 [No Abstract] [Full Text] [Related]
19. [Arguments for a uniform pathogenesis of polyetiologic arterial occlusions]. Hess H; Frost H Verh Dtsch Ges Kreislaufforsch; 1969; 35():333-40. PubMed ID: 5380611 [No Abstract] [Full Text] [Related]
20. [Treatment of peripheral vascular disorders with vasculat]. GALOTTO MARTORELL J Med Interna (Bucur); 1959 Oct; 42():322-7. PubMed ID: 13826195 [No Abstract] [Full Text] [Related] [Next] [New Search]